Differential modulation of energy balance by leptin, ciliary neurotrophic factor, and leukemia inhibitory factor gene

V Prima1, M Tennant, O S Gorbatyuk

  • 1Department of Molecular Genetics and Microbiology, Powell Gene Therapy Center, University of Florida, Gainesville, Florida 32610-0266, USA.

Endocrinology
|January 13, 2004
PubMed

Insights

Ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor show potential for weight management by mimicking leptin signaling. However, sustained brain expression may cause inflammation and adverse effects, cautioning against their therapeutic use.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Molecular Biology

Background:

  • Obesity is often linked to leptin resistance, limiting leptin therapy effectiveness in animal models.
  • Ciliary neurotrophic factor (CNTF) offers an alternative by activating leptin-like pathways to bypass leptin resistance.

Purpose of the Study:

  • To investigate the molecular effects of sustained central expression of leptin, CNTF, and leukemia inhibitory factor (LIF) in the rat hypothalamus.
  • To elucidate the mechanisms behind the weight-reducing and anorexigenic actions of these cytokines.

Main Methods:

  • Viral vector-mediated central delivery of transgenes encoding leptin, CNTF, and LIF in rats.
  • Analysis of body weight gain and food intake to assess metabolic responses.
  • Gene expression profiling of 1300 brain-specific genes in hypothalami after 10 weeks of cytokine exposure.

Main Results:

  • Leptin, CNTF, and LIF induced comparable, yet distinct, metabolic effects, including reduced weight gain and altered food intake.
  • Sustained cytokine expression led to gene expression changes indicative of chronic inflammation in the brain.
  • CNTF resulted in temporary weight reduction, while LIF caused severe cachexia.

Conclusions:

  • Constitutive brain expression of these cytokines can trigger inflammatory responses.
  • While CNTF and LIF show potential for weight management, their use is cautioned due to risks of inflammation and severe cachexia.
  • Further research is needed to evaluate the safety and efficacy of cytokine-based therapies for obesity.